OncoMed Pharmaceuticals Inc: cashflow_operating
| Value | {"amount": -84970000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | current |
| Entity | OncoMed Pharmaceuticals Inc |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:24:59.902707+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c9cc74dc-38fd-4f5b-b916-e6cd52a477d6
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-19-006795 · Open the official SEC filing →Retrieved: 2026-08-19T12:24:59.902707+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001302573/cashflow-operating/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c9cc74dc-38fd-4f5b-b916-e6cd52a477d6
History
- supersedes {"amount": -84970000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} (evidence 0001564590-18-005014)